Breaking News
Investing Pro 0
🚨 Our Pro Data Reveals the True Winner of Earnings Season Access Data

Dow Bags Gain on Value Stocks; FDA Approves Gilead's Anti-Viral Drug

Stock Markets Oct 22, 2020 04:08PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters.
 
AAPL
+0.90%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
GOOG
+1.96%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
AAL
+1.13%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
ALK
+2.35%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
META
+1.30%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
IXIC
+1.67%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

By Yasin Ebrahim

Investing.com – The Dow closed higher Thursday, as value stocks plugged the gap left by a fall in tech stocks on signs of progress on stimulus after House Speaker Nancy Pelosi suggested a deal was close.

Gilead Sciences Inc (NASDAQ:GILD) jumped 4% in after-hours trading after the FDA approved its anti-viral drug.

The Dow Jones Industrial Average rose 0.55%, or 154 points. The S&P 500 was up 0.55%, while the Nasdaq Composite added 0.57%.

Pelosi said a deal on stimulus “just about there," though added that key issues including state and local funding as well as liability protection were yet to be resolved.

Still, as any eventual stimulus proposal would need backing from congress, there is likely to be further stumbling blocks ahead. Senate GOP leader Mitch McConnell has expressed concerns over the size of the deal on the table, believed to be around $1.9 trillion, still below the Democrats' $2.2 trillion proposal, preferring instead to roll out targeted relief measures.  

In another boost to sentiment on the economy, jobless claims fell below 800,000 for the first since the pandemic struck in mid-March.

The Labor Department said 787,000 people filed for unemployment insurance, down 55,000 from the prior week's downwardly revised 842,000, and well above economists' forecast for 870,000.

Some economists, however, questioned whether the trend will continue in the wake of rising Covid-19 cases.

"[W]e doubt it will continue as Covid infections spread rapidly, pushing down demand for discretionary consumer services, especially in the hospitality sector," Pantheon Macroeconomics said in a note.

The renewed hopes for the economic recovery to continue, however, triggered a climb in value stocks with financials and energy in the ascendency.

Energy jumped 4% as oil prices clawed back some of their losses from a day earlier, when a jump in gasoline supplies intensified fears of demand weakening.

Financials, meanwhile, were pushed higher by a sharp uptick in banking stocks as the favorable backdrop of rising Treasury yields continued.

Wells Fargo (NYSE:WFC) added 2%, while Bank of America (NYSE:BAC) and JPMorgan Chase (NYSE:JPM) climbed more than 3%.

The earnings parade gathered pace as mega blue chips reported quarterly performance.

Tesla Inc (NASDAQ:TSLA) eased from session highs to end nearly 1% after the electric automaker said it was on track to for 500,000 deliveries this year, and reported quarterly results that beat on both the top and bottom lines.

Coca-Cola Company (NYSE:KO) added 1% after its better-than-expected quarterly results suggested the worst of the hit from pandemic was in the rearview mirror as sales fell 6% in the quarter, a marked improvement from the 26% slump in the second quarter.

Airlines, among the hardest hit sectors from the pandemic, reporting mixed results as American Airlines (NASDAQ:AAL) reported narrower-than-expected results, while Alaska Air Group Inc (NYSE:ALK) revealed deeper losses, though said it had cut its cash burn.

Tech was among the biggest decliners on the day as the fab 5 traded slipped. Apple (NASDAQ:AAPL), Amazon.com (NASDAQ:AMZN), Facebook (NASDAQ:FB) were below the flatline, while Microsoft (NASDAQ:MSFT) finished flat and Google-parent Alphabet (NASDAQ:GOOGL) rose 1%.

On the vaccine front, The Federal Food and Drug Administration approved Gilead (NASDAQ:GILD)'s remdesivir to treat patients with COVID-19 requiring hospitalization. "The drug is now widely available in hospitals across the country, following early investments to rapidly expand manufacturing capacity to increase supply," the company said.

Dow Bags Gain on Value Stocks; FDA Approves Gilead's Anti-Viral Drug
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (14)
Liew Chee Fah
Liew Chee Fah Oct 23, 2020 3:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
How much this drug manufacturer funded coming from USA presidential election?
Yuge Profits
InTheMoney Oct 22, 2020 7:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
no one wants remdesivir
New Jazenevd
New Jazenevd Oct 22, 2020 7:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Remdesivir efficiency has been verified by comprehensive FDA study. The latter is the only authority to approve new medicines in this country. On the other hand, “WHO study” is a purely fictional thing, invented and promoted by media to serve obvious political purposes.
Irvin Mermelstein
Irvin Mermelstein Oct 22, 2020 7:16PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Remdisivir was found to in ineffective at saving any lives by a huge WHO study--71,000 cases. This is pure politics and the SEC should look at this. Enough.
Ben Ma
Ben Ma Oct 22, 2020 6:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
there is no value in this bubble market
Randall Wagner
Randall Wagner Oct 22, 2020 6:30PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Thanks president Trump, job well done fighting the virus!
New Jazenevd
New Jazenevd Oct 22, 2020 6:14PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
GILD presents good investment opportunity, esp. now with share price artificially depressed, mostly by political reasons.
Amine Fourali
Amine Fourali Oct 22, 2020 6:14PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Artificially depressed... are you serious?
New Jazenevd
New Jazenevd Oct 22, 2020 6:14PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Amine Fourali  Certainly, I am serious. Btw, many stocks are depressed on pumped up on market. Did not you know this?
Jozef Drozd
Jozef Drozd Oct 22, 2020 6:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://time.com/5901087/remdesivir-conflicting-studies/
Jozef Drozd
Jozef Drozd Oct 22, 2020 6:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it doesn't work !
Lakshmana Reddy
Lakshmana Reddy Oct 22, 2020 5:30PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
News for 1 month for markets up
Jozef Drozd
Jozef Drozd Oct 22, 2020 5:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I have heard that according to WHO this drug ( remdesivir )  doesn't work at all ?
Danny Danny
Danny Danny Oct 22, 2020 5:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Do you really believe what WHO says? The head of it is a communist.
pet kur
PeterKuram Oct 22, 2020 5:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Danny Danny what a ridiculous comment. Tell your brain cell to wake the other one up. It needs help.
Jozef Drozd
Jozef Drozd Oct 22, 2020 5:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.rxlist.com/consumer_remdesivir_rdv/drugs-condition.htm
Amine Fourali
Amine Fourali Oct 22, 2020 5:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
pet kur well said
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email